Double-labelled HIV-1 particles for study of virus-cell interaction

Virology

Volumn 360, Issue 1, 2007, Pages 92-104

  Lampe, Marko ^a   Briggs, John A G ^b   Endress, Thomas ^b   Glass, Bärbel ^a   Riegelsberger, Stefan ^b   Kräusslich, Hans Georg ^a   Lamb, Don C ^b,c   Bräuchle, Christoph ^b   Müller, Barbara ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c University of Illinois at Urbana Champaign   (United States)

Author keywords

Fluorescence labelling; Heparan sulfate; HIV 1; Single virus tracing; Virus entry

Indexed keywords

CELL PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCENT DYE; MATRIX PROTEIN; VIRUS FUSION PROTEIN; VPR PROTEIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS PARTICLE;

BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; GENE PRODUCTS, VPR; GREEN FLUORESCENT PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; LUMINESCENT PROTEINS; STAINING AND LABELING; VIRAL MATRIX PROTEINS; VIROLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847267353     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.10.005     Document Type: Article

References (36)

1. Bobardt M.D., Saphire A.C., Hung H.C., Yu X., Van der Schueren B., Zhang Z., David G., and Gallay P.A. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 18 1 (2003) 27-39
2. Bohne J., and Kräusslich H.G. Mutation of the major 5′ splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing. FEBS Lett. 563 (2004) 113-118
3. Bräuchle C., Seisenberger G., Endress T., Ried M.U., Buning H., and Hallek M. Single virus tracing: visualization of the infection pathway of a virus into a living cell. ChemPhysChem 3 3 (2002) 299-303
4. Briggs J.A., Wilk T., Welker R., Kräusslich H.G., and Fuller S.D. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J. 22 7 (2003) 1707-1715
5. Briggs J.A., Simon M.N., Gross I., Kräusslich H.G., Fuller S.D., Vogt V.M., and Johnson M.C. The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol. Biol. 11 7 (2004) 672-675
6. Campbell R.E., Tour O., Palmer A.E., Steinbach P.A., Baird G.S., Zacharias D.A., and Tsien R.Y. A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. U.S.A. 99 12 (2002) 7877-7882
7. Cavrois M., De Noronha C., and Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20 11 (2002) 1151-1154
8. Daecke J., Fackler O.T., Dittmar M.T., and Kräusslich H.G. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J. Virol. 79 3 (2005) 1581-1594
9. Damm E.M., Pelkmans L., Kartenbeck J., Mezzacasa A., Kurzchalia T., and Helenius A. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168 3 (2005) 477-488
10. Eckert D.M., and Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70 (2001) 777-810
11. Emi N., Friedmann T., and Yee J.K. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65 3 (1991) 1202-1207
12. Ewers H., Smith A.E., Sbalzarini I.F., Lilie H., Koumoutsakos P., and Helenius A. Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes. Proc. Natl. Acad. Sci. U.S.A. 102 42 (2005) 15110-15115
13. Finke S., Brzozka K., and Conzelmann K.K. Tracking fluorescence-labeled rabies virus: enhanced green fluorescent protein-tagged phosphoprotein P supports virus gene expression and formation of infectious particles. J. Virol. 78 22 (2004) 12333-12343
14. Gallo S.A., Finnegan C.M., Viard M., Raviv Y., Dimitrov A., Rawat S.S., Puri A., Durell S., and Blumenthal R. The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta 1614 1 (2003) 36-50
15. Ibrahim J., Griffin P., Coombe D.R., Rider C.C., and James W. Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes. Virus Res. 60 2 (1999) 159-169
16. Lakadamyali M., Rust M.J., Babcock H.P., and Zhuang X. Visualizing infection of individual influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 100 16 (2003) 9280-9285
17. Lehmann M.J., Sherer N.M., Marks C.B., Pypaert M., and Mothes W. Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells. J. Cell Biol. 170 2 (2005) 317-325
18. Markosyan R.M., Cohen F.S., and Melikyan G.B. Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane. Mol. Biol. Cell 16 12 (2005) 5502-5513
19. Matlin K.S., Reggio H., Helenius A., and Simons K. Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156 (1982) 609-631
20. McDonald D., Vodicka M.A., Lucero G., Svitkina T.M., Borisy G.G., Emerman M., and Hope T.J. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 159 3 (2002) 441-452
21. Mondor I., Ugolini S., and Sattentau Q.J. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72 5 (1998) 3623-3634
22. Müller B., Tessmer U., Schubert U., and Kräusslich H.G. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells. J. Virol. 74 20 (2000) 9727-9731
23. Müller B., Daecke J., Fackler O.T., Dittmar M.T., Zentgraf H., and Kräusslich H.G. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 78 19 (2004) 10803-10813
24. Münk C., Brandt S.M., Lucero G., and Landau N.R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. U.S.A. 99 21 (2002) 13843-13848
25. Palokangas H., Metsikko K., and Vaananen K. Active vacuolar H+ATPase is required for both endocytic and exocytic processes during viral infection of BHK-21 cells. J. Biol. Chem. 269 26 (1994) 17577-17585
26. Platt E.J., Wehrly K., Kuhmann S.E., Chesebro B., and Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72 (1998) 2855-2864
27. Raviv Y., Viard M., Bess Jr. J., and Blumenthal R. Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling. Virology 293 2 (2002) 243-251
28. Rust M.J., Lakadamyali M., Zhang F., and Zhuang X. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat. Struct. Mol. Biol. 11 6 (2004) 567-573
29. Seisenberger G., Ried M.U., Endress T., Buning H., Hallek M., and Bräuchle C. Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science 294 5548 (2001) 1929-1932
30. Sieczkarski S.B., and Whittaker G.R. Viral entry. Curr. Top. Microbiol. Immunol. 285 (2005) 1-23
31. Sherer N.M., Lehmann M.J., Jimenez-Soto L.F., Ingmundson A., Horner S.M., Cicchetti G., Allen P.G., Pypaert M., Cunningham J.M., and Mothes W.R. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4 11 (2003) 785-801
32. Suomalainen M., Nakano M.Y., Keller S., Boucke K., Stidwill R.P., and Greber U.F. Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell Biol. 144 4 (1999) 657-672
33. Ugolini S., Mondor I., and Sattentau Q.J. HIV-1 attachment: another look. Trends Microbiol. 7 4 (1999) 144-149
34. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., and Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46 6 (2002) 1896-1905
35. Wilk T., Gross I., Gowen B.E., Rutten T., de Haas F., Welker R., Kräusslich H.G., Boulanger P., and Fuller S.D. Organization of immature human immunodeficiency virus type 1. J. Virol. 75 2 (2001) 759-771
36. Zhang Y.J., Hatziioannou T., Zang T., Braaten D., Luban J., Goff S.P., and Bieniasz P.D. Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection. J. Virol. 76 12 (2002) 6332-6343